Trillium Asset Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.87M Sell
11,314
-270
-2% -$62.9K 0.09% 147
2026
Q1
$2.83M Sell
11,584
-704
-6% -$164K 0.09% 140
2025
Q4
$2.54M Sell
12,288
-83
-0.7% -$16.4K 0.08% 147
2025
Q3
$2.29M Sell
12,371
-122
-1% -$20.9K 0.06% 151
2025
Q2
$1.91M Buy
12,493
+9
+0.1% +$1.38K 0.05% 152
2025
Q1
$2.07M Sell
12,484
-213
-2% -$33.3K 0.06% 153
2024
Q4
$1.84M Sell
12,697
-526
-4% -$81.5K 0.05% 158
2024
Q3
$2.14M Sell
13,223
-50
-0.4% -$7.97K 0.05% 161
2024
Q2
$1.94M Sell
13,273
-730
-5% -$109K 0.05% 165
2024
Q1
$2.21M Sell
14,003
-55
-0.4% -$8.75K 0.06% 161
2023
Q4
$2.2M Sell
14,058
-954
-6% -$146K 0.06% 156
2023
Q3
$2.34M Sell
15,012
-516
-3% -$85.1K 0.07% 153
2023
Q2
$2.57M Sell
15,528
-731
-4% -$118K 0.07% 149
2023
Q1
$2.66M Buy
16,259
+168
+1% +$27.1K 0.08% 140
2022
Q4
$2.84M Sell
16,091
-353
-2% -$61K 0.09% 143
2022
Q3
$2.69M Buy
16,444
+403
+3% +$68.2K 0.09% 142
2022
Q2
$2.85M Sell
16,041
-32,988
-67% -$5.88M 0.09% 143
2022
Q1
$8.69M Buy
49,029
+29,399
+150% +$5M 0.23% 103
2021
Q4
$3.36M Buy
19,630
+1,734
+10% +$284K 0.08% 156
2021
Q3
$2.89M Sell
17,896
-6,859
-28% -$1.17M 0.08% 154
2021
Q2
$4.08M Sell
24,755
-1,626
-6% -$269K 0.11% 135
2021
Q1
$4.34M Buy
26,381
+2,670
+11% +$432K 0.14% 124
2020
Q4
$3.73M Sell
23,711
-45
-0.2% -$6.64K 0.13% 118
2020
Q3
$3.54M Sell
23,756
-1,270
-5% -$188K 0.15% 110
2020
Q2
$3.52M Sell
25,026
-1,860
-7% -$271K 0.15% 115
2020
Q1
$3.53M Sell
26,886
-43
-0.2% -$6.1K 0.19% 114
2019
Q4
$3.93M Sell
26,929
-46,445
-63% -$6.3M 0.17% 126
2019
Q3
$9.49M Sell
73,374
-32,251
-31% -$4.25M 0.44% 85
2019
Q2
$14.7M Buy
105,625
+85
+0.1% +$11.8K 0.71% 47
2019
Q1
$14.8M Buy
105,540
+16,534
+19% +$2.21M 0.75% 44
2018
Q4
$11.5M Sell
89,006
-4,503
-5% -$628K 0.66% 57
2018
Q3
$12.9M Sell
93,509
-430
-0.5% -$57.1K 0.65% 59
2018
Q2
$11.4M Buy
93,939
+22,193
+31% +$2.77M 0.61% 64
2018
Q1
$9.19M Buy
71,746
+3,268
+5% +$442K 0.51% 76
2017
Q4
$9.57M Sell
68,478
-802
-1% -$112K 0.53% 79
2017
Q3
$9.01M Sell
69,280
-18,714
-21% -$2.48M 0.51% 82
2017
Q2
$11.6M Buy
87,994
+13
+0% +$1.66K 0.69% 58
2017
Q1
$11M Sell
87,981
-3,974
-4% -$475K 0.7% 56
2016
Q4
$10.6M Sell
91,955
-1,539
-2% -$178K 0.7% 58
2016
Q3
$11M Sell
93,494
-655
-0.7% -$79.5K 0.71% 61
2016
Q2
$11.4M Sell
94,149
-287
-0.3% -$32.6K 0.75% 53
2016
Q1
$10.2M Sell
94,436
-870
-0.9% -$90.1K 0.68% 60
2015
Q4
$9.79M Buy
95,306
+1,015
+1% +$102K 0.66% 65
2015
Q3
$8.8M Buy
94,291
+929
+1% +$89.9K 0.62% 67
2015
Q2
$9.1M Buy
93,362
+3,098
+3% +$310K 0.58% 67
2015
Q1
$9.08M Buy
90,264
+295
+0.3% +$30K 0.59% 66
2014
Q4
$9.41M Sell
89,969
-12,327
-12% -$1.3M 0.64% 57
2014
Q3
$10.9M Sell
102,296
-590
-0.6% -$61.2K 0.94% 39
2014
Q2
$10.8M Buy
102,886
+9,640
+10% +$974K 0.92% 39
2014
Q1
$9.16M Buy
93,246
+299
+0.3% +$27.7K 0.86% 45
2013
Q4
$8.51M Buy
92,947
+2,041
+2% +$188K 0.84% 48
2013
Q3
$7.88M Sell
90,906
-627
-0.7% -$56.2K 0.88% 47
2013
Q2
$7.86M Buy
+91,533
New +$7.77M 0.97% 41

Other funds holding JNJ

Trillium Asset Management's JNJ Position: Q2 2026 in Review

Trillium Asset Management reduced its Johnson & Johnson (JNJ) stake by 2.3% in Q2 2026, selling an estimated $62.9K and leaving 11,314 shares worth $2.87M. The position accounts for 0.09% of the portfolio, ranked #147.

Trillium Asset Management first reported a position in JNJ in Q2 2013 and has held it in 53 quarters since. The position peaked at $14.8M in Q1 2019. 4,665 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Trillium Asset Management held 11,314 shares of Johnson & Johnson worth $2.87M as of Q2 2026.
  • Trillium Asset Management sold 270 Johnson & Johnson shares in Q2 2026, an estimated $62.9K.
  • Johnson & Johnson made up 0.09% of Trillium Asset Management's portfolio in Q2 2026, its #147 holding.
  • Trillium Asset Management first reported a position in Johnson & Johnson in Q2 2013 and has held it in 53 quarters since.
  • Trillium Asset Management's Johnson & Johnson position peaked at $14.8M in Q1 2019.
  • 4,665 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Trillium Asset Management's 13F filing for Q2 2026, filed 11 Aug 2026.